% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/E1684-data.R
\docType{data}
\name{E1684}
\alias{E1684}
\title{ECOG E1684 Trial}
\format{
A data frame with 262 rows and 8 variables:
\describe{
\item{failtime}{time to relapse in years}
\item{failcens}{censoring indicator for time to relapse, 0 = did not relapse, 1 = relapsed}
\item{survtime}{time to death in years}
\item{survcens}{censoring indicator for time to death, 0 = alive, 1 = dead}
\item{treatment}{treatment indicator, 0 = observation, 1 = high-dose IFN}
\item{sex}{gender indicator, 0 = male, 1 = female}
\item{age}{patient age in years}
\item{node_bin}{indicator for having more than one cancerous lymph node,
0 = with one or no cancerous lymph nodes,
1 = with more than one cancerous lymph node}
}
}
\usage{
E1684
}
\description{
A data set from the ECOG E1684 trial comparing the high-dose interferon alfa-2b (IFN)
therapy with the observation in resected high-risk melanoma patients. The study results
were described in Kirkwood et al. (1996) \url{doi:10.1200/JCO.1996.14.1.7}.
}
\references{
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., and Blum, R. H. (1996). Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684. Journal of Clinical Oncology, 14(1), 7â€“17.
}
\keyword{data}
